| First 3 months | Last 3 months | ||
---|---|---|---|---|
 | Adjusted HR (95%CI) | P-value | Adjusted HR (95%CI) | P-value |
Sex | ||||
  Male | a |  | Reference |  |
  Female | a |  | 0.83 (0.70–0.97) | 0.02 |
Age in years | ||||
  18 to 30 years | a |  | Reference |  |
  31 to 40 years | a |  | 0.97 (0.80–1.19) | 0.80 |
  41 to 50 years | a |  | 0.95 (0.75–1.20) | 0.66 |
  51 + years | a |  | 1.26 (1.02–1.55) | 0.03 |
Patient type | ||||
  New cases | a |  | Reference |  |
  Re-treatment cases | a |  | 1.57 (1.28–1.93) | <0.001 |
Nutrition status | ||||
  Undernourished | 0.96 (0.86–1.07) | 0.47 | a |  |
  Normal BMI | Reference |  | a |  |
  Overweight | 0.85 (0.73–0.98) | 0.04 | a |  |
HIV status | ||||
  HIV uninfected | Reference |  | Reference |  |
  HIV infected on ARVS | 1.08 (0.98–1.20) | 0.13 | 1.65 (1.39–1.96) | <0.001 |
  HIV infected not on ARVS | 1.72 (1.28–2.30) | <0.001 | 2.56 (1.39–4.72) | 0.003 |
  Unknown HIV status | 1.12 (0.74–1.68) | 0.60 | 0.92 (0.34–2.46) | 0.86 |
  Underlying conditions | a |  | 2.24 (1.41–3.54) | 0.001 |
TB diagnosis | ||||
  Bacteriologically confirmed | a |  | Reference |  |
  Clinical signs | a |  | 0.82 (0.70–0.97) | 0.02 |
Year of starting treatment | ||||
  2012 | Reference |  | Reference |  |
  2013 | 1.56 (1.20–2.02) | 0.001 | 1.37 (0.95–1.98) | 0.10 |
  2014 | 1.55 (1.22–1.96) | <0.001 | 1.67 (1.16–2.40) | 0.005 |
  2015 | 1.58 (1.24–2.00) | <0.001 | 2.24 (1.57–3.20) | <0.001 |
  2016 | 1.40 (1.11–1.76) | 0.004 | 3.06 (2.17–4.31) | <0.001 |
  2017 | 1.79 (1.42–2.25) | <0.001 | 2.80 (1.99–3.94) | <0.001 |
  2018 | 1.93 (1.55–2.39) | <0.001 | 2.48 (1.77–3.47) | <0.001 |
  2019 | 1.59 (1.27–1.99) | <0.001 | 2.30 (1.62–3.27) | <0.001 |
AUCs (95% CI) | 0.60 (0.58–0.62) | 0.64 (0.63–0.65) |